Center for Digestive Diseases, Karolinska University Hospital
Stockholm, 14186, Sweden
NCT Number: NCT03118310
The impact of popular diets on liver-related health is unclear. In this randomized, controlled trial, patients with NAFLD will be randomized to one of two popular diets or a placebo diet.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 2
Stockholm, 14186, Sweden
Subjects will include patients with MRI-verified NAFLD, with no concurrent liver diseases. Randomization will be done to either a control diet, the 5:2 diet or a low-carb-high-fat diet. The subjects will follow the diet for three months, after which a new MRI is performed. Main outcomes measure is reduction in liver fat.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dietary intervention according to 5:2 diet during three months.
Dietary intervention according to LCHF diet during three months.
Placebo diet: normal dietary advice
Time frame: Three months
MRI-measured liver fat content
Karolinska University Hospital
Other
Acronym: TREND
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03656744
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chandler, Arizona, United States
View Trial DetailsNCT04987879
Digestive System Diseases, Fatty Liver
Hershey, Pennsylvania, United States
View Trial DetailsNCT06176079
Digestive System Diseases, Fatty Liver
San Francisco, California, United States
View Trial DetailsNCT04248335
Body Weight, Deglutition Disorders
Kansas City, Missouri, United States
View Trial Details